Skip to main content
REDUCE THE URGE TO SCRATCH BY 88% WITH OUR NEW ATODERM AD INTENSIVE BALM SHOP NOW
AD Intensive Balm - Texture
AD Intensive Balm - Ecobiological Mode of Action
AD Intensive Balm - Instruction for use
AD Intensive Balm
AD Intensive Balm - Proof of Efficacy / Benefits / Still Lifes
AD Intensive Balm - Composition
AD Intensive Balm
AD Intensive Balm
AD Intensive Balm
New

Atoderm AD Intensive Balm

Very dry to atopic skin

  • 1 second to soothe*
  • Reduces the urge to scratch by 88%**
Buy online

Very dry to atopic skin
ATODERM AD INTENSIVE BALM
Product type
Daily skincare
For
Adults, Babies, Children
Benefits
•Instant soothing: 1 second to soothe itching sensations (1)
•Protects from scratching: Reduces the urge to itch by 88% (6) 
•Transforms daily life: 6 months without flare-ups (7), 3× less impact on social activities and daily life (12), -92% insomnia (13)
•Shield effect against allergenic and irritating particles (pollution, cat hair, peanuts, mold, dust mites) (2) (3)

Unfragranced. Non sticky. Non greasy. Allows you to dress immediately. Very high skin tolerance. Tested under dermatological & pediatric control. Safe from birth.

Compatible with medical treatments (such as topical corticosteroids).

Sources
*Clinical study under dermatological control, on 30 adult subjects with atopic dermatitis and significant pruritus using Atoderm AD Intensive baume for 7 days. Self-assessment under medical control after the first application (Argentina, 2025)**Clinical study under dermatological control, on 32 adult subjects with irritant or allergic contact dermatitis, using Atoderm AD Intensive baume for 28 days. Self-grading (Mauritius, 2025).

This product was formulated according to the ecobiological approach of the NAOS Laboratories to take care of you. At the heart of this product:

LIPIDACTIVE technology : 15 missing lipids decoded to restore missing lipids in eczema-prone skin to rebuild the skin barrier, including:•\tNATURAL PLANT OILS (like coconut, jojoba, meadowfoam oils): replenish the skin and provide immediate comfort•\tPRO-CERAMIDES: help to rebuild the skin barrier for long-lasting itch soothing

The ingredients listed here are those contained in the most recent formulation of this product. As there may be a delay between its production and its distribution on the market, please refer to the ingredient list on the packaging.

morning/evening
body
body and face

Apply once to twice a day to cleaned skin. Face and body. Babies, children, adults. Do not apply on oozing skin. If skin irritation persists, consult a healthcare professional. Store at room temperature.

  1. Wash your skin beforehand with a gentle cleanser.
  2. Apply AD Intensive Balm to the skin.
  3. Gently massage until absorbed.

Immediate results

1) SOOTHES IMMEDIATLY ITCHING SENSATIONS:

> 1 second to soothe (1);

2) PROTECTS FROM TRIGGERING FACTORS FROM THE VERY 1ST USE:

Shield effects againt the following triggering factors: -92% cat allergen (2), -80% pollution particles (3), -99.9% proliferation of S. aureus (4).

3) HYDRATION FOR 24H (5)

Long-term results

1) LASTINGLY SOOTHES ITCHING SENSATIONS:

> Reduces the urge to scratch by 88%  (6)

> 6 months without flare-ups (7)

2) LASTINGLY STRENGTHENS THE SKIN BARRIER AGAINST TRIGGERING FACTORS:

> Reactivates the biological synthesis of key skin barrier components: 

proteins (+180% loricrin (8), +22% filaggrin (8), +250% claudin-1  (10)) and lipids (+51% ceramides (9)) ;

> Reinforces the skin barrier: -29% TEWL after 8 days(11); 


3) IMPROVES QUALITY OF LIFE

> Eczema-prone skin has 3x less impact on social activities and daily life(12)
> Sleep quality improves: -92% insomnia after 6 months (13)
> Skin regains comfort and a healthier appearance: -84% dryness (13), -76% redness (13) after 6 months

Sources

Cavallo A, Camera E, Bottillo G, Maiellaro M, Truglio M, Marini F, Chavagnac-Bonneville M, Fauger A, Perrier E, Pigliacelli F, Picardo M, Cristaudo A, Mariano M. Biosignatures of defective sebaceous gland activity in sebum-rich and sebum-poor skin areas in adult atopic dermatitis. Exp Dermatol. 2024 Mar;33(3):e15066.

1.Clinical study under dermatological control, on 30 adult subjects with atopic dermatitis and significant pruritus using Atoderm AD Intensive baume for 7 days. Self-assessment under medical control after the first application (Argentina, 2025)
2.Ex vivo study of physical protection against cat allergens penetration by Atoderm AD Intensive baume on skin biopsies, versus untreated condition. Quantification by immunostaining and image analysis. Other allergens were also tested: -85% peanut allergens, -81% mold allergens, -71% house dust mite allergens (France, 2025).
3.Clinical study on 10 subjects, evaluation of physical protection of Atoderm AD Intensive baume against pollution particles deposition on skin. Instrumental measure by colorimetry (France, 2024)
4.In vitro study of protection efficacy of Atoderm AD Intensive baume against proliferation of Staphylococcus aureus under biofilm form, versus control condition. Counting of bacteria after 4h-incubation (France, 2024)
5.Clinical study on 10 subjects for 24h, instrumental measurement of hydration by corneometry (France, 2023)
6.Clinical study under dermatological control, on 32 adult subjects with irritant or allergic contact dermatitis, using Atoderm AD Intensive baume for 28 days. Self-grading (Mauritius, 2025).
7.Helps space out flare-ups of severe dryness. Clinical study under dermatological control, on 88 children with light to moderate atopic dermatitis, using either Atoderm AD Intensive baume or a neutral cream, for 6 months. Self-reporting: 88% of subjects without any reported flare-ups for 6 months with Atoderm AD Intensive baume (Poland, 2024-2025).
8.Ex vivo study of loricrin and filaggrin synthesis by cytokines-stressed skin biopsies, after LIPIDACTIVE technology topical application versus stressed untreated condition. Quantification by immunostaining of proteins and image analysis (France, 2024).
9.Ex vivo study of ceramides synthesis by stripped skin biopsies, after LIPIDACTIVE technology topical application versus stripped untreated condition. Quantification by liquid chromatography and mass spectrometry. +51% NP long-chain ceramides (France, 2025).
10.In vitro study of claudin-1 (tight junction) synthesis by stressed human primary keratinocytes, with SKIN BARRIER SEALER technology versus stressed control condition. Quantification by immunostaining of proteins and image analysis (France, 2020)
11.Clinical study under dermatological control, on 43 adult subjects with moderate atopic dermatitis using either Atoderm AD Intensive baume or a neutral cream, in routine with Atoderm Huile de douche, for 37 days. Instrumental measure on non-lesional area (Georgia, winter 2025).
12.Clinical study under dermatological control, on 88 children with light to moderate atopic dermatitis, using either Atoderm AD Intensive baume or a neutral cream, for 6 months. Self-grading of CDLQI, question n°3 and n°5 versus neutral cream.
13.Clinical study under dermatological control, on 88 children with light to moderate atopic dermatitis, using either Atoderm AD Intensive baume or a neutral cream, for 6 months.. Clinical grading, sub-score of SCORAD (Poland, 2024-2025).

Skin Barrier Therapy™ patent image
Prevents the adhesion and proliferation of bacteria

The patented Skin Barrier Therapy™ technology prevents the adhesion, in the form of a biofilm, of certain bacteria (Staphylococcus aureus) involved in the aggravation of severe, dry skin.

This patent by NAOS Research was designed in Aix-en-Provence.

Skin Barrier Therapy™ patent

FAQ

Your most frequently asked questions about AD Intensive Balm

Atoderm AD Intensive Balm meets the needs of very dry, atopic-prone skin by providing deep hydration and essential lipids. This emollient balm helps restore the skin’s natural barrier function, while reducing the urge to scratch. Atoderm AD Intensive Balm contains BIODERMA’s Lipidactive Technology, designed to replenish essential lipids identified as missing in atopic skin thanks to lipidomic research (1). Moreover, by promoting the biological synthesis of lipids (many ceramides) and proteins (filaggrin and loricrin), it helps restore the skin barrier over time. During clinical studies, subjects with eczema stated that Atoderm AD Intensive Balm soothed the skin from the very first fist second (2). Clinical testing also showed it reduces the urge to scratch by 88% (3). Applying Atoderm AD Intensive Balm twice a day also increased comfort with 0 flare-ups for 6 months (4).1 Biosignatures of defective sebaceous gland activity in sebum-rich and sebum-poor skin areas in adult atopic dermatitis. Exp Dermatol. 2024 Mar;33(3):e15066. Cavallo A, Camera E, Bottillo G, Maiellaro M, Truglio M, Marini F, Chavagnac-Bonneville M, Fauger A, Perrier E, Pigliacelli F, Picardo M, Cristaudo A, Mariano M. 2 Clinical study under dermatological control, on 30 adult subjects with chronic atopic dermatitis and significant pruritus using Atoderm AD Intensive Balm . Self-assessment under medical control after the first application (Argentina, 2025)3 Clinical study under dermatological control, on 32 adult subjects with irritant or allergic contact dermatitis, using Atoderm AD Intensive Balm for 28 days. Self-grading (Mauritius, 2025).4 Clinical study under dermatological and pediatric control, on 88 children with light to moderate atopic dermatitis, using either Atoderm AD Intensive Balm or a neutral cream, for 6 months. Self-reporting: 88% of subjects without any reported flare-ups for 6 months with Atoderm AD Intensive Balm (Poland, 2024-2025).

This anti-itch balm acts immediately and over time. Atoderm AD Intensive Balm soothed itching sensations in just one second (1) as assessed during clinical testing. Subjects reported an immediate reduction in scratching and experienced greater comfort over time with 0 flares-up for 6 months (2). 1 Clinical study under dermatological control, on 30 adult subjects with chronic atopic dermatitis and significant pruritus using Atoderm AD Intensive Balm. Self-assessment under medicaltechnical control after the first application (Argentina, 2025)2 Clinical study under dermatological and pediatric control, on 88 children with light to moderate atopic dermatitis, using either Atoderm AD Intensive Balm or a neutral cream, for 6 months. Self-reporting: 88% of subjects without any reported flare-ups for 6 months with Atoderm AD Intensive Balm (Poland, 2024-2025).

Atoderm AD Intensive Balm is an anti-itch cream formulated for very dry, irritated and atopic-prone skin. It contains 15 biomimetic lipids identified as missing in atopic skin - thanks to lipidomic research (1) - and that help relaunch lipids and proteins biological synthesis to rebuild the skin barrier lastingly. Atoderm AD Intensive Balm can be applied to the body and face, morning and evening, as part of a daily care routine, alongside a gentle cleansing product such as Atoderm Shower oil.1 Biosignatures of defective sebaceous gland activity in sebum-rich and sebum-poor skin areas in adult atopic dermatitis. Exp Dermatol. 2024 Mar;33(3):e15066. Cavallo A, Camera E, Bottillo G, Maiellaro M, Truglio M, Marini F, Chavagnac-Bonneville M, Fauger A, Perrier E, Pigliacelli F, Picardo M, Cristaudo A, Mariano M.

Very dry and atopic-prone skin requires nourishing care after cleansing, at least once a day. If your skin pulls or itches, apply morning and night. For an eczema flare-up, keep applying the balm alongside any treatments prescribed by your doctor, unless advised otherwise. Atoderm AD Intensive Balm is suitable for all types of eczema, anywhere on the body and demonstrated to be very well tolerated, even in association of topical corticosteroids.To obtain the best results with an anti-itch product like Atoderm AD Intensive Balm, consistent application is essential. This helps limit flare-ups and restore the skin’s natural balance over time.

Atoderm AD Intensive Balm is safe for adults, children and babies from birth. This anti-itch balm has been dermatologically and pediatrically tested. The high-tolerance formula contains 96% biomimetic ingredients , formulated without silicon, mineral oils, perfume or alcohol.

Eczema can affect people at any age and may require a medical diagnosis and prescription treatments from a healthcare professional. Atoderm AD Intensive Balm is compatible with medical treatments, including topical corticosteroids.During eczema flare-ups, it can be used alongside prescribed treatments. It may be applied before, after or in between treatments, based on your routine and medical advice. Some dermatologists recommend applying the emollient before topical treatments during flare-ups.For optimal results, apply Atoderm AD Intensive Balm every day, all year round, once to twice daily, to the entire body — both affected areas and non-lesional skin— to help maintain skin hydration and support long-term barrier repair.Atoderm AD Intensive Balm is formulated for high tolerance and has been dermatologically tested on atopic and eczema-prone skin.If the eye area is dry or affected by eczema and contribute to alleviate itching sensations, use a product specifically formulated for this delicate area such as Atoderm Intensive eye.